NCT04642066

Brief Summary

The impact of the environment on human health is considerable. An important factor is the effect of temperature on the human body, where either the effects of short-term exposure to extreme temperatures (cryotherapy, sauna, etc.) or the long-term environmental impact are monitored. The study was focused on research of the long-term effect of repeated CWI on atherogenesis, lipid parameters and fat distribution.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Oct 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Oct 2018Jun 2026

Study Start

First participant enrolled

October 25, 2018

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

November 18, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 24, 2020

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

November 18, 2023

Status Verified

November 1, 2023

Enrollment Period

7.2 years

First QC Date

November 18, 2020

Last Update Submit

November 15, 2023

Conditions

Outcome Measures

Primary Outcomes (10)

  • Body mass index

    BMI kg/m2

    6 months

  • Change in total cholesterol from baseline

    percentual change in total cholesterol (mmoL/L)

    6 months

  • Concentrations of PCSK9, hsCRP and other inflammation markers

    mmol/l

    6 months

  • cIMT

    mm

    6 months

  • PWV

    m/s

    6 months

  • Beta

    6 months

  • AU

    6 months

  • SF

    mm

    6 months

  • VF

    mm

    6 months

  • Fatty acid profile

    mol/l

    6 months

Study Arms (2)

Active Group

EXPERIMENTAL

Healthy volunteers were followed during the 5-month CWI exposition under standard conditions (three times per week 7-10 min). Neoprene equipment was not allowed; volunteers with followed weight or muscle mass changes over 5% were excluded

Other: Cold water immersion

Sham control

SHAM COMPARATOR

Control without CWI exposition

Other: No cold water immersion

Interventions

Full body CWI in open standing, except the head (same location, timing), frequency three times a week in the duration of 7-10 minutes. Swimming was permitted. Volunteers must not use neoprene aids (gloves, shoes), caps were allowed. Volunteers should be in the final phase submerged in water, above which there should only be the head and neck. The upper limbs were below the water surface. Non-neoprene footwear was permitted. Volunteers entered the water continuously without stopping. The time of stay in water was calculated from the first contact of the foot with water. On average, the whole body needed to be immersed in water within 30 seconds.

Active Group

People without cold water immersion

Sham control

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • without cardiovascular and metabolic disease cold water immersion

You may not qualify if:

  • cancer inflammatory diseases cardovascular diseases tuberculosis renal and hepatic insufficiency pregnancy cardiovascular diseases obesity metabolic syndrome lymphoproliferative disorders liver transplantation in the past suspected. chronic infection in risk locations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

1st Department of Internal medicine, L. Pasteur University Hospital in Košice

Košice, 04011, Slovakia

Location

MeSH Terms

Conditions

Immune System Diseases

Study Officials

  • Stefan Tóth, MUDr., PhD

    Pavol Joef Safárik University, Faculty of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 18, 2020

First Posted

November 24, 2020

Study Start

October 25, 2018

Primary Completion

December 30, 2025

Study Completion (Estimated)

June 30, 2026

Last Updated

November 18, 2023

Record last verified: 2023-11

Locations